| |
| |
|
| Insider
Information: |
Amello Jason |
| Relationship: |
Chief Financial Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
369,028 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$219,289 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
369,028 |
|
|
| Total
Value |
$219,289 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -69.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Genzyme Corp |
GENZ |
CorpContrllr,ChiefAccn... |
2011-04-04 |
0 |
|
0 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Executive Vice Preside... |
2013-05-08 |
22,377 |
2012-05-08 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2020-02-28 |
144,642 |
2014-03-25 |
0 |
Premium* |
|
|
Candel Therapeutics, Inc. |
CADL |
Chief Financial Officer |
2023-11-28 |
202,009 |
2022-11-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CADL |
Candel Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-11-28 |
4 |
D |
$0.90 |
$18,138 |
D/D |
(20,153) |
202,009 |
0 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
125,717 |
222,162 |
0 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-09 |
4 |
B |
$1.93 |
$4,763 |
D/D |
2,468 |
5,568 |
2.66 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-12-08 |
4 |
B |
$1.69 |
$5,239 |
D/D |
3,100 |
3,100 |
2.74 |
- |
|
| CADL |
Candel Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
90,877 |
90,877 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2020-02-28 |
4 |
S |
$8.70 |
$60,691 |
D/D |
(6,976) |
144,642 |
0 |
% |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
151,618 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2019-04-11 |
4 |
D |
$7.70 |
$101,240 |
D/D |
(13,148) |
118,618 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
131,766 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2018-12-12 |
4 |
D |
$8.94 |
$198,781 |
D/D |
(22,235) |
66,501 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
87,236 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2017-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
65,637 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2016-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
33,330 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2014-11-26 |
4 |
B |
$13.22 |
$13,220 |
D/D |
1,000 |
5,000 |
2.74 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
SVP, CFO & Treasurer |
• – – |
2014-03-25 |
4 |
B |
$17.00 |
$68,000 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President & CFO |
• – – |
2013-05-08 |
4 |
D |
$1.65 |
$4,328 |
D/D |
(2,623) |
22,377 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Executive Vice President & CFO |
• – – |
2012-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| GENZ |
Genzyme Corp |
CorpContrllr,ChiefAccntOfficer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$370,370 |
D/D |
(5,005) |
0 |
0 |
- |
|
| GENZ |
Genzyme Corp |
CorpContrllr,ChiefAccntOfficer |
• – – |
2011-04-04 |
4 |
D |
$74.00 |
$154,216 |
D/D |
(2,084) |
5,005 |
0 |
- |
|
| GENZ |
Genzyme Corp |
CorpContrllr,ChiefAccntOfficer |
• – – |
2011-04-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,005 |
7,089 |
0 |
- |
|
| GENZ |
Genzyme Corp |
CorpContrllr,ChiefAccntOfficer |
• – – |
2010-08-31 |
5 |
OE |
$46.24 |
$307,034 |
D/D |
6,640 |
1,633 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Corp Contrllr,ChiefAccntOfficr |
• – – |
2010-08-31 |
4 |
OE |
$46.24 |
$307,034 |
D/D |
6,640 |
9,910 |
0 |
- |
|
| GENZ |
Genzyme Corp |
Corp Contrllr,ChiefAccntOfficr |
• – – |
2010-08-31 |
4 |
S |
$70.30 |
$466,792 |
D/D |
(6,640) |
3,270 |
0 |
- |
|
| GENZ |
Genzyme Corp |
CorpContrllr,ChiefAccntOfficer |
• – – |
2010-07-26 |
5 |
S |
$65.25 |
$67,991 |
D/D |
(1,042) |
1,633 |
0 |
- |
|
| GENZ |
Genzyme Corp |
CorpContrllr,ChiefAccntOfficer |
• – – |
2010-07-23 |
5 |
S |
$62.95 |
$37,455 |
D/D |
(595) |
2,675 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
